• Loading stock data...

Financial News

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) Stock Increases On Successful Phase II Ganaxolone Study

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced the successful completion of Phase II Epilepsy study after examining the potential candidate, ganaxolone, for treatment of patients suffering...

Antares Pharma Inc (NASDAQ:ATRS) Announces Positive Phase III Trials That Support Xyosted Approval

Antares Pharma Inc (NASDAQ:ATRS) announced recently the positive Phase III trials that may support the approval of Xyosted , which was initially known as...

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) is Far More than Meets the Eye

Following our enormous win the junior gold mining space earlier this month, we are now ready to turn our attention to another market segment...

Verastem Inc (NASDAQ:VSTM) Blood Cancer Program Succeeds In Final Phase Trial

Verastem Inc (NASDAQ:VSTM) announced recently that its new drug to treat selected blood cancer indications have met the essential goal of the late-stage study....

Palatin Technologies, Inc. (NYSEMKT:PTN) Signs Licensing Agreement With Shanghai Fosun Pharmaceutical (Group) For Rights...

Palatin Technologies, Inc. (NYSEMKT:PTN) and Shanghai Fosun Pharmaceuticals (Group) have signed a licensing agreement to manufacture and commercialize the bremelanotide drug, which treats Female...

Signup To Receive Our E-Alerts on the Market’s Latest Trends in Cannabis, Energy, Health Care, Metals & Technology.

X